Treatment, promotion, commotion: Antibiotic alternatives in food-producing animals

Trends in Microbiology

Volumn 21, Issue 3, 2013, Pages 114-119

  Allen, Heather K ^a   Levine, Uri Y ^a   Looft, Torey ^a   Bandrick, Meggan ^a   Casey, Thomas A ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Antibiotic alternatives; Feed additives; Metagenomics.; Microbiota; Phage therapy; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; FOOD ADDITIVE; GROWTH PROMOTOR; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; VACCINE;

ANIMAL HUSBANDRY; ANIMAL WELFARE; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BODY GROWTH; DRUG CLASSIFICATION; DRUG CONTROL; DRUG TARGETING; DRUG USE; FOOD AND DRUG ADMINISTRATION; FOOD INDUSTRY; GASTROINTESTINAL TRACT; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFECTION; INTESTINE FLORA; LIVESTOCK; MOLECULAR THERAPY; NONHUMAN; PHAGE THERAPY; POULTRY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; TRANSLATIONAL RESEARCH; VACCINATION; VETERINARY MEDICINE;

ANIMAL HUSBANDRY; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; GROWTH SUBSTANCES; VETERINARY MEDICINE;

EID: 84875259457     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2012.11.001     Document Type: Review

References (52)

1. Cromwell G.L. Why and how antibiotics are used in swine production. Anim. Biotechnol. 2002, 13:7-27.
2. Holt J.P., et al. Growth performance and antibiotic tolerance patterns of nursery and finishing pigs fed growth-promoting levels of antibiotics. Livest. Sci. 2011, 136:184-191.
3. Proceedings, First International Conference on the Use of Antibiotics in Agriculture 1956, Agriculture Board, National Research Council, National Academy of Sciences.
4. Stanton T. A call for antibiotic alternatives research. Trends Microbiol. 2013, 21:111-113.
5. Center for Veterinary Medicine, Food and Drug Administration (2012) The judicious use of medically important antimicrobial drugs in food-producing animals. Guidance for Industry #209, 1-26, http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM216936.pdf.
6. Center for Veterinary Medicine, Food and Drug Administration (2012) New animal drugs and new animal drug combination products administered in or on medicated feed or drinking water of food-producing animals: recommendations for drug sponsors for voluntarily aligning product use conditions with GFI #209. Guidance for Industry #213, 1-18, http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM299624.pdf.
7. Aarestrup F.M. Characterization of glycopeptide-resistant Enterococcus faecium (GRE) from broilers and pigs in Denmark: genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides. J. Clin. Microbiol. 2000, 38:2774-2777.
8. Aarestrup F.M., et al. Changes in the use of antimicrobials and the effects on productivity of swine farms in Denmark. Am. J. Vet. Res. 2010, 71:726-733.
9. Cotter P.D., et al. The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing. Discov. Med. 2012, 13:193-199.
10. Kau A.L., et al. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
11. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8:411-420.
12. Sekirov I., et al. Gut microbiota in health and disease. Physiol. Rev. 2010, 90:859-904.
13. Hooper L.V., et al. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
14. Dibner J.J., Buttin P. Use of organic acids as a model to study the impact of gut microflora on nutrition and metabolism. J. Appl. Poult. Res. 2002, 11:453.
15. Niewold T.A. The nonantibiotic anti-inflammatory effect of antimicrobial growth promoters, the real mode of action? A hypothesis. Poult. Sci. 2007, 86:605-609.
16. Butaye P., et al. Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on Gram-positive bacteria. Clin. Microbiol. Rev. 2003, 16:175-188.
17. Hardy B. The issue of antibiotic use in the livestock industry: what have we learned?. Anim. Biotechnol. 2002, 13:129-147.
18. Looft T., Allen H.K. Collateral effects of antibiotics on mammalian gut microbiomes. Gut Microbes 2012, 3:463-467.
19. Gibson G.R., et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 2004, 17:259-275.
20. Wales A.D., et al. Chemical treatment of animal feed and water for the control of Salmonella. Foodborne Pathog. Dis. 2010, 7:3-15.
21. Dunne C., et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am. J. Clin. Nutr. 2001, 73:386S-392S.
22. Guo X., et al. Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs. Antonie Van Leeuwenhoek 2006, 90:139-146.
23. Musa H., et al. The potential benefits of probiotics in animal production and health. J. Anim. Vet. Adv. 2009, 8:313-321.
24. Callaway T., et al. Probiotics, prebiotics and competitive exclusion for prophylaxis against bacterial disease. Anim. Health Res. Rev. 2008, 9:217-225.
25. Soccol C.R., et al. The potential of probiotics: a review. Food Technol. Biotechnol. 2010, 48:413-434.
26. Gaggìa F., et al. Probiotics and prebiotics in animal feeding for safe food production. Int. J. Food Microbiol. 2010, 141:S15.
27. Vondruskova H., et al. Alternatives to antibiotic growth promoters in prevention of diarrhoea in weaned piglets: a review. Vet. Med. Czech. 2010, 55:199-224.
28. Modesto M., et al. A novel strategy to select Bifidobacterium strains and prebiotics as natural growth promoters in newly weaned pigs. Livest. Sci. 2009, 122:248-258.
29. Abedon S.T., et al. Phage treatment of human infections. Bacteriophage 2011, 1:66-85.
30. Merabishvili M., et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE 2009, 4:e4944.
31. Berchieri A., et al. The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella Typhimurium. Res. Microbiol. 1991, 142:541-549.
32. Callaway T.R., et al. Evaluation of phage treatment as a strategy to reduce Salmonella populations in growing swine. Foodborne Pathog. Dis. 2011, 8:261-266.
33. Smith H.W., Huggins M.B. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol. 1982, 128:307-318.
34. Merril C.R., et al. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:3188-3192.
35. Pirnay J.P., et al. The phage therapy paradigm: pret-a-porter or sur-mesure?. Pharm. Res. 2011, 28:934-937.
36. Brussow H. Phage therapy: the Western perspective. Bacteriophage: Genetics and Microbiology 2007, 159-192. Caister Academic Press. S. McGrath (Ed.).
37. Fischetti V.A. Bacteriophage lysins as effective antibacterials. Curr. Opin. Microbiol. 2008, 11:393-400.
38. Schmitz J.E., et al. Identifying active phage lysins through functional viral metagenomics. Appl. Environ. Microbiol. 2010, 76:7181-7187.
39. Bak H., Rathkjen P. Reduced use of antimicrobials after vaccination of pigs against procine proliferative enteropathy in a Danish SPF herd. Acta Vet. Scand. 2009, 51:1.
40. Heo J.M., et al. Gastrointestinal health and function in weaned pigs: a review of feeding strategies to control post-weaning diarrhoea without using in-feed antimicrobial compounds. J. Anim. Physiol. Anim. Nutr. 2012, 10.1111/j.1439-0396.2012.01284.x.
41. Kroll J., et al. Evaluation of protective immunity in pigs following oral administration of an avirulent live vaccine of Lawsonia intracellularis. Am. J. Vet. Res. 2004, 65:559-565.
42. Roof M.B., Doitchinoff D.D. Safety, efficacy, and duration of immunity induced in swine by use of an avirulent live Salmonella choleraesuis-containing vaccine. Am. J. Vet. Res. 1995, 56:39-44.
43. Francis D.H., Willgohs J.A. Evaluation of a live avirulent Escherichia coli vaccine for K88+, LT+ enterotoxigenic colibacillosis in weaned pigs. Am. J. Vet. Res. 1991, 52:1051-1055.
44. 192A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibits adherence of K88 (F4) and F18 fimbriae, and protects pigs against K88ac/heat-labile toxin infection. Clin. Vaccine Immunol. 2011, 18:1593-1599.
45. Song Y., et al. A reverse vaccinology approach to swine dysentery vaccine development. Vet. Microbiol. 2009, 137:111-119.
46. Bomba A., et al. The possibilities of potentiating the efficacy of probiotics. Trends Food Sci. Technol. 2002, 13:121-126.
47. Methner U., et al. Combination of vaccination and competitive exclusion to prevent Salmonella colonization in chickens: experimental studies. Int. J. Food Microbiol. 1999, 49:35-42.
48. Frana T.S., et al. Effects of microcin 24-producing Escherichia coli on shedding and multiple-antimicrobial resistance of Salmonella enterica serotype Typhimurium in pigs. Am. J. Vet. Res. 2004, 65:1616-1620.
49. Zilber-Rosenberg I., Rosenberg E. Prebiotics and probiotics within the framework of the hologenome concept. J. Microb. Biochem. Technol. 2011, S1:2.
50. Cho I., Blaser M.J. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 2012, 13:260-270.
51. Van den Abbeele P., et al. The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept. FEMS Microbiol. Rev. 2011, 35:681-704.
52. Little A.E., et al. Rules of engagement: interspecies interactions that regulate microbial communities. Annu. Rev. Microbiol. 2008, 62:375-401.